<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of neonatal <z:hpo ids='HP_0000979'>purpura</z:hpo> fulminans associated with activated protein C resistance </plain></SENT>
<SENT sid="1" pm="."><plain>Analysis of DNA demonstrated heterozygosity for the factor V R506Q mutation </plain></SENT>
<SENT sid="2" pm="."><plain>The neonate, at 8 hours of age, had progressive purpuric <z:mp ids='MP_0001212'>skin lesions</z:mp> and later had evidence of microvascular, hemorrhagic <z:mp ids='MP_0005048'>thrombosis</z:mp> in the brain </plain></SENT>
<SENT sid="3" pm="."><plain>The baby was treated with fresh frozen plasma infusions and had complete resolution of the <z:mp ids='MP_0001212'>skin lesions</z:mp> and no apparent long-term complications </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that activated protein C resistance testing be included in the initial evaluation of neonatal <z:hpo ids='HP_0000979'>purpura</z:hpo> fulminans </plain></SENT>
</text></document>